Chondrodystrophy – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:30:55 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Chondrodystrophy – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Safety and Effects of SAR442501 for Children with Achondroplasia https://clinicaltrials.eu/trial/study-on-the-safety-and-effects-of-sar442501-for-children-with-achondroplasia/ Wed, 29 Apr 2026 14:26:50 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-and-effects-of-sar442501-for-children-with-achondroplasia/ This clinical trial is focused on studying Achondroplasia, a condition that affects bone growth, leading to shorter stature. The study will use a treatment called SAR442501, which is a special type of protein known as a humanised monoclonal antibody derivative against fibroblast growth factor receptor 3. This treatment is given as a powder that is mixed into a solution and then injected under the skin.

The purpose of the study is to understand how safe and tolerable SAR442501 is for children with Achondroplasia. Participants will receive the treatment through subcutaneous injections, which means the medicine is injected just under the skin. The study will take place over a period of time, and participants will be monitored for any side effects or changes in their condition. The study will also look at how the treatment affects growth and development in children with Achondroplasia.

Throughout the study, researchers will collect information on various aspects of the participants’ health, including growth rates, body proportions, and overall quality of life. This information will help determine how the treatment works in the body and its potential benefits for children with Achondroplasia. The study aims to provide valuable insights into the treatment’s effectiveness and safety, contributing to better care for those with this condition.

]]>